Articles
As the new COVID-19 virus has spread worldwide, Companies and institutions of all sizes and across all sectors are being faced with difficult situations to keep their employees safe during this pandemic.
Governments around the world are rapidly responding to the covid-19 pandemic, and social distancing is a vital aspect of strategy to limit the spread of the covid-19. As social distancing has to be followed diligently; health care providers are turning to alternative measures for patient care with no direct contact, including telemedicine and Virtual Medical Scribe Services. Necessitate for Virtual Medical Scribe and Speech Software’s Health care industries are mainly affected because of this covid-19. As the virus continues to spread, patients looking for medical help are…
Governments around the world are rapidly responding to the covid-19 pandemic, and social distancing is a vital aspect of strategy to limit the spread of the covid-19. As social distancing has to be followed diligently; health care providers are turning to alternative measures for patient care with no direct contact, including telemedicine and Virtual Medical Scribe Services. Necessitate for Virtual Medical Scribe and Speech Software’s Health care industries are mainly affected because of this covid-19. As the virus continues to spread, patients looking for medical help are…
As the nation deals with social distancing and staying indoors more as a result of the outbreak of Covid-19, concerns have been raised about the impact this could have on people’s mental health. James de Bathe, director of partnerships at Ieso Digital Health, explores how online mental health services could be a better way of reaching the UK population.
As the nation deals with social distancing and staying indoors more as a result of the outbreak of Covid-19, concerns have been raised about the impact this could have on people’s mental health. James de Bathe, director of partnerships at Ieso Digital Health, explores how online mental health services could be a better way of reaching the UK population. According to Public Health England, one in six adults will have experienced a common…
As the nation deals with social distancing and staying indoors more as a result of the outbreak of Covid-19, concerns have been raised about the impact this could have on people’s mental health. James de Bathe, director of partnerships at Ieso Digital Health, explores how online mental health services could be a better way of reaching the UK population. According to Public Health England, one in six adults will have experienced a common…
29-Jun-2020
For literally everyone - where social distancing is not possible facial respiratory masks have become an invaluable line of defense against the coronavirus and will apply to those who are unable to keep six feet away from others in public settings, on a bus or subway, on a crowded sidewalk, in a classroom, or in large social and athletic events. Mitigating liabilities inherent in acquiring appropriate facial respiratory protection requires empirically correct information. The threat to all nations has never been higher in our lifetimes.
Sometimes in our lifetimes we witness a rare convergence of market need and technology. The market need today is easily identified – the worldwide demand for new personal protection products and innovations that effectively lead to successful mitigation of…
Sometimes in our lifetimes we witness a rare convergence of market need and technology. The market need today is easily identified – the worldwide demand for new personal protection products and innovations that effectively lead to successful mitigation of…
The U.S. Food and Drug Administration approved a new application of a current pleural mesothelioma treatment, according to a press release Monday from Eagle Pharmaceuticals.
The U.S. Food and Drug Administration approved a new application of a current pleural mesothelioma treatment, according to a press release Monday from Eagle Pharmaceuticals. The FDA approved pemetrexed injection for patients who are not surgical candidates. Pemetrexed is the generic name for the chemotherapy drug Alimta, which is administered intravenously. The injection version of pemetrexed is branded Pemfexy. The new treatment method will not be available until February 1, 2022. Pemetrexed is one of two FDA-approved chemotherapy drugs for mesothelioma. The other is cisplatin. The press release from Eagle Pharmaceutic…
The U.S. Food and Drug Administration approved a new application of a current pleural mesothelioma treatment, according to a press release Monday from Eagle Pharmaceuticals. The FDA approved pemetrexed injection for patients who are not surgical candidates. Pemetrexed is the generic name for the chemotherapy drug Alimta, which is administered intravenously. The injection version of pemetrexed is branded Pemfexy. The new treatment method will not be available until February 1, 2022. Pemetrexed is one of two FDA-approved chemotherapy drugs for mesothelioma. The other is cisplatin. The press release from Eagle Pharmaceutic…
25-Nov-2025
If you are new to telecommuting, it may feel like someone dropped you in the deep forest without a compass. Many of the routines that tell you what to do when in the office go out the window. While it’s natural to feel unsettled, you need structure to work at your productive best.
How to Organise Your Day When Working from Home If you are new to telecommuting, it may feel like someone dropped you in the deep forest without a compass. Many of the routines that tell you what to do when in the office go out the window. While it’s natural to feel unsettled, you need structure to work at your productive best. Once you master the art of working from home, you’ll likely find that you accomplish more than ever. Follow the tips below to develop a routine that lets you produce your best work. Mak…
How to Organise Your Day When Working from Home If you are new to telecommuting, it may feel like someone dropped you in the deep forest without a compass. Many of the routines that tell you what to do when in the office go out the window. While it’s natural to feel unsettled, you need structure to work at your productive best. Once you master the art of working from home, you’ll likely find that you accomplish more than ever. Follow the tips below to develop a routine that lets you produce your best work. Mak…
The question of which expertise to trust has always been a tricky, sometimes even touchy subject. Nowhere is this better evidenced than the COVID-19 crisis. Every nation in the world – from Sweden to Saudi Arabia has had its own scientific community put under the microscope.
The question of which expertise to trust has always been a tricky, sometimes even touchy subject. Nowhere is this better evidenced than the COVID-19 crisis. Every nation in the world – from Sweden to Saudi Arabia has had its own scientific community put under the microscope. Misinformation continues to circulate through global health networks, to the detriment of individual countries’ ability to respond effectively to the pandemic. Even the World Health Organization’s expertise has come under unprecedented scrutiny in…
The question of which expertise to trust has always been a tricky, sometimes even touchy subject. Nowhere is this better evidenced than the COVID-19 crisis. Every nation in the world – from Sweden to Saudi Arabia has had its own scientific community put under the microscope. Misinformation continues to circulate through global health networks, to the detriment of individual countries’ ability to respond effectively to the pandemic. Even the World Health Organization’s expertise has come under unprecedented scrutiny in…
“Supply chain planning in life sciences has always been complex. It is a highly regulated sector; pharmaceuticals products typically have limited life spans, and supply chains are often based on functional silos. Planning cycles can sometimes extend over 5-10 years. Excess inventory can also be a problem but the overriding concern is getting products quickly out to end users to keep them well.
“Supply chain planning in life sciences has always been complex. It is a highly regulated sector; pharmaceuticals products typically have limited life spans, and supply chains are often based on functional silos. Planning cycles can sometimes extend over 5-10 years. Excess inventory can also be a problem but the overriding concern is getting products quickly out to end users to keep them well. Th…
“Supply chain planning in life sciences has always been complex. It is a highly regulated sector; pharmaceuticals products typically have limited life spans, and supply chains are often based on functional silos. Planning cycles can sometimes extend over 5-10 years. Excess inventory can also be a problem but the overriding concern is getting products quickly out to end users to keep them well. Th…
Regulatory teams have much to learn from the standardised approach that quality assurance colleagues take to managing information. The legacy, document-based view of information management is fast being replaced by a data-first approach. Up-to-date, high quality data is key to success, argues Romuald Braun, VP of Strategy for Life Sciences, AMPLEXOR.
Regulatory teams have much to learn from the standardised approach that quality assurance colleagues take to managing information. The legacy, document-based view of information management is fast being replaced by a data-first approach. Up-to-date, high quality data is key to success, argues Romuald Braun, VP of Strategy for Life Sciences, AMPLEXOR. Across pharma businesses, teams work together to meet Regulatory commitments, perhaps sharing u…
Regulatory teams have much to learn from the standardised approach that quality assurance colleagues take to managing information. The legacy, document-based view of information management is fast being replaced by a data-first approach. Up-to-date, high quality data is key to success, argues Romuald Braun, VP of Strategy for Life Sciences, AMPLEXOR. Across pharma businesses, teams work together to meet Regulatory commitments, perhaps sharing u…
Here's a list of awareness days for Healthcare and Pharma for 2020. Note that this is not an exhaustive list, and if you spot any errors or omissions, let me know.
January National Blood Donor Month National Glaucoma Awareness Month National Volunteer Blood Donor Month Cervical Cancer Awareness Month National Birth Defects Prevention Month Dry January 19-25th: National Activities Professional Week 25th: National Intravenous Nurse Day February American Heart Month AMD/Low Vision Awareness Month National Cancer Prevention Month National Senior Independence Month Feb. 1-7: Patient Recognition Week Feb. 3-7: Pride in Food Service Week Feb. 9-15: National Cardiac Rehabilitation Week Feb. 14-21: Alzheimer's and Dementia Staff Education Week February 4th: World Cancer Day …
January National Blood Donor Month National Glaucoma Awareness Month National Volunteer Blood Donor Month Cervical Cancer Awareness Month National Birth Defects Prevention Month Dry January 19-25th: National Activities Professional Week 25th: National Intravenous Nurse Day February American Heart Month AMD/Low Vision Awareness Month National Cancer Prevention Month National Senior Independence Month Feb. 1-7: Patient Recognition Week Feb. 3-7: Pride in Food Service Week Feb. 9-15: National Cardiac Rehabilitation Week Feb. 14-21: Alzheimer's and Dementia Staff Education Week February 4th: World Cancer Day …
Investing in structured content management/authoring capabilities without first establishing a supporting backbone is like buying a Porsche when there are no suitable roads to drive on. Amplexor’s Agnes Cwienczek suggests a more sustainable approach.
Today, there are numerous external and internal drivers for life sciences organisations to be collecting, preparing, publishing/submitting and managing more and more data, and to be doing this more and more using a structured format. Regulatory agencies are demanding increased safety and traceability detail; requirements about what goes on packaging and labelling are becoming more stringent; and the public is calling for greater transparency about the products they use. Meanwhile, companies need to be smarter, faster and more cost-efficient in…
Today, there are numerous external and internal drivers for life sciences organisations to be collecting, preparing, publishing/submitting and managing more and more data, and to be doing this more and more using a structured format. Regulatory agencies are demanding increased safety and traceability detail; requirements about what goes on packaging and labelling are becoming more stringent; and the public is calling for greater transparency about the products they use. Meanwhile, companies need to be smarter, faster and more cost-efficient in…
Providing electronic product information, something international health authorities are steadily moving towards as a requirement, promises to be a much more efficient and user-friendly way of conveying the latest manufacturing details and safety recommendations to patients and healthcare professionals. But how ready are life sciences companies, asks Amplexor’s Agnes Cwienczek.
Providing electronic product information, something international health authorities are steadily moving towards as a requirement, promises to be a much more efficient and user-friendly way of conveying the latest manufacturing details and safety recommendations to patients and healthcare professionals. But how ready are life sciences companies, asks Amplexor’s Agnes Cwienczek. Continued reliance on paper-based ins…
Providing electronic product information, something international health authorities are steadily moving towards as a requirement, promises to be a much more efficient and user-friendly way of conveying the latest manufacturing details and safety recommendations to patients and healthcare professionals. But how ready are life sciences companies, asks Amplexor’s Agnes Cwienczek. Continued reliance on paper-based ins…
PharmiWeb is pleased to announce the launch of our IOS Job Search App for the pharma and life science sector.
PharmiWeb is pleased to announce the launch of our IOS Job Search App for the pharma and life science sector. Even in these times, PharmiWeb’s niche job board (PharmiWeb.Jobs) maintains a vast selection of active job vacancies from countries right across Europe and into Australia. The new app is designed to help job seekers quickly search over 2500 current vacancies from more than 80 actively recruiting employers and agencies. Once installed, job seekers can save their searches, shortlist the roles or apply online using their hand held devices. Developed by our platform partner Madgex, our IOS app complements our existing Android app already available on the Google App…
PharmiWeb is pleased to announce the launch of our IOS Job Search App for the pharma and life science sector. Even in these times, PharmiWeb’s niche job board (PharmiWeb.Jobs) maintains a vast selection of active job vacancies from countries right across Europe and into Australia. The new app is designed to help job seekers quickly search over 2500 current vacancies from more than 80 actively recruiting employers and agencies. Once installed, job seekers can save their searches, shortlist the roles or apply online using their hand held devices. Developed by our platform partner Madgex, our IOS app complements our existing Android app already available on the Google App…
Why are Safety & Pharmacovigilance departments lagging in their application of smart technology, when the pressures on pharmaceutical organisations to capture, sift and process real-world adverse event data are vast, asks John Price, a life sciences regulatory and safety consultant and advisor to Arriello.
Compared with other functions across the pharmaceutical product lifecycle, Safety and Pharmacovigilance (PV) teams are the least likely to employ smart technology to help lighten the load. This is surprising given that life sciences companies today spend a disproportionate amount of their PV budget simply amassing reports of suspected drug reactions - which are often of poor quality. So what’s stopping them exploiting proven technology to lighten the load? Building the business case In pr…
Compared with other functions across the pharmaceutical product lifecycle, Safety and Pharmacovigilance (PV) teams are the least likely to employ smart technology to help lighten the load. This is surprising given that life sciences companies today spend a disproportionate amount of their PV budget simply amassing reports of suspected drug reactions - which are often of poor quality. So what’s stopping them exploiting proven technology to lighten the load? Building the business case In pr…
Peter Kohut, Director of Drug safety at Arriello, explores the main hurdles preventing greater automation of PV data capture processes within life sciences firms, and suggests a way forward
Peter Kohut, Director of Drug safety at Arriello, explores the main hurdles preventing greater automation of PV data capture processes within life sciences firms, and suggests a way forward. With more and more safety data to capture, and a window of just 15 days to assess and report serious adverse events to health authorities, the case for automating the most labour-intensive aspects of pharmacovigilance (PV), is strong. So, what is holding companies back from investing in process transformation? 1. A lack of suitable solutions Look at most other industries, especially thos…
Peter Kohut, Director of Drug safety at Arriello, explores the main hurdles preventing greater automation of PV data capture processes within life sciences firms, and suggests a way forward. With more and more safety data to capture, and a window of just 15 days to assess and report serious adverse events to health authorities, the case for automating the most labour-intensive aspects of pharmacovigilance (PV), is strong. So, what is holding companies back from investing in process transformation? 1. A lack of suitable solutions Look at most other industries, especially thos…
Founded in 2010, Innovative Trials works alongside pharmaceutical and clinical research organisations to ensure that patients enrol onto clinical trials in a timely manner and are fully informed of what the research will involve for themselves and their families. This enables potential new treatments to come to market as early as possible to provide alternative therapeutic options for present and future patients.
Based in Letchworth Garden City in Hertfordshire, Innovative Trials employs around 45 members of staff in the UK. The company works internationally with a further 63 people stationed overseas in 58 countries to help clinical trial researchers recruit eligible patients and keep them involved.
For more information, visit www.innovativetrials.co.uk
Clinical trial patient recruit…
Clinical trial patient recruit…
For decades now, global consumers have relied on blanket advice when it comes to their health and wellbeing, with guidance frequently centred on eating well, exercising frequently and sleeping for a recommended period per night.
Annemie Venter, R&D Director, External Product Development – Outside Innovation, Health For decades now, global consumers have relied on blanket advice when it comes to their health and wellbeing, with guidance frequently centred on eating well, exercising frequently and sleeping for a recommended period per night. Whilst these adages are still absolutely true, recent decades have witnessed significant advancements in genetics, which have paved the way for a far more personalised approach to maintaining and improving health and wellbeing. One field where these…
Annemie Venter, R&D Director, External Product Development – Outside Innovation, Health For decades now, global consumers have relied on blanket advice when it comes to their health and wellbeing, with guidance frequently centred on eating well, exercising frequently and sleeping for a recommended period per night. Whilst these adages are still absolutely true, recent decades have witnessed significant advancements in genetics, which have paved the way for a far more personalised approach to maintaining and improving health and wellbeing. One field where these…
Amplexor’s David Gwyn highlights 5 areas where richer, more holistic product information – compiled in response to regulatory requirements – could help transform business outcomes.
In the consumer world, smartphone apps are transforming people’s visibility, into their consumption habits for example, helping them to make better choices. Now the same needs to happen in life sciences, based on more unified product and regulatory status insights. In the 2020s, breaking down walls, consolidating disparate applications, and behaving more cohesively as a unified global business with end-to-end operational visibility, is a commercial imperative. Whatever the short- and longer-term fallout of Covid-19, organisations will need to come back fighting – with new tools at their disposal, ready to raise t…
In the consumer world, smartphone apps are transforming people’s visibility, into their consumption habits for example, helping them to make better choices. Now the same needs to happen in life sciences, based on more unified product and regulatory status insights. In the 2020s, breaking down walls, consolidating disparate applications, and behaving more cohesively as a unified global business with end-to-end operational visibility, is a commercial imperative. Whatever the short- and longer-term fallout of Covid-19, organisations will need to come back fighting – with new tools at their disposal, ready to raise t…
Intelligent analytics and smart process automation rely 100 per cent on the trustworthiness of underlying data. Steve Gens of Gens & Associates and Remco Munnik of Iperion Life Sciences Consultancy offer five best-practice tips for achieving and maintaining integrity across company-wide product information to create a sure footing for AI-driven innovation.
Intelligent analytics and smart process automation rely 100 per cent on the trustworthiness of underlying data. Steve Gens of Gens & Associates and Remco Munnik of Iperion Life Sciences Consultancy offer five best-practice tips for achieving and maintaining integrity across company-wide product information to create a sure footing for AI-driven innovation. ‘New’ technologies including artificial intelligence/machine learning (AI/ML) o…
Intelligent analytics and smart process automation rely 100 per cent on the trustworthiness of underlying data. Steve Gens of Gens & Associates and Remco Munnik of Iperion Life Sciences Consultancy offer five best-practice tips for achieving and maintaining integrity across company-wide product information to create a sure footing for AI-driven innovation. ‘New’ technologies including artificial intelligence/machine learning (AI/ML) o…
If standardised medicinal product data is to be of tangible real-world benefit, it’s vital that momentum around IDMP is not lost in 2020, warns Iperion’s Remco Munnik
Substantial investment has gone into the preparations for the EU’s implementation of the ISO IDMP (identification of medicinal products) standards, which must not be compromised in 2020 - whatever the current hold-ups with European Medicines Agency’s IDMP implementation guidelines, and despite the new Veterinary Regulation vying for attention. The goal of IDMP is to create a current central data repository of medicinal products that can be readily searched, understood and relied upon internationally. SPOR (Substance, Product, Organisation and Referential) data management services are the key to enabling this, paving the way fo…
Substantial investment has gone into the preparations for the EU’s implementation of the ISO IDMP (identification of medicinal products) standards, which must not be compromised in 2020 - whatever the current hold-ups with European Medicines Agency’s IDMP implementation guidelines, and despite the new Veterinary Regulation vying for attention. The goal of IDMP is to create a current central data repository of medicinal products that can be readily searched, understood and relied upon internationally. SPOR (Substance, Product, Organisation and Referential) data management services are the key to enabling this, paving the way fo…
From personalised medicine and cannabis oil, to track and trace and the Falsified Medicines Directive (FMD), the pharmaceutical industry has witnessed a whole host of changes over the past decade. But what does the future hold? Here, Adrian Pittock, marketing director at pharmaceutical consumables supplier Valley Northern, looks at pharmaceutical trends for 2020.
~ Exploring AI, blockchain and packaging ~ From personalised medicine and cannabis oil, to track and trace and the Falsified Medicines Directive (FMD), the pharmaceutical industry has witnessed a whole host of changes over the past decade. But what does the future hold? Here, Adrian Pittock, marketing director at pharmaceutical consumables supplier Valley Northern, looks at pharmaceutical trends for 2020. Artificial intelligence Ar…
~ Exploring AI, blockchain and packaging ~ From personalised medicine and cannabis oil, to track and trace and the Falsified Medicines Directive (FMD), the pharmaceutical industry has witnessed a whole host of changes over the past decade. But what does the future hold? Here, Adrian Pittock, marketing director at pharmaceutical consumables supplier Valley Northern, looks at pharmaceutical trends for 2020. Artificial intelligence Ar…
